Xiaohe Li
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies 9
- Hepatology top 5%
- Hepatitis C virus research 10
- Neurology top 5%
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 40
- Neonatal Respiratory Health Research 7
- Modeling and Simulation top 5%
-
- Liver Disease Diagnosis and Treatment 17
- Hepatitis B Virus Studies 9
-
- Spine and Intervertebral Disc Pathology 7
-
- Spinal Fractures and Fixation Techniques 6
- Co-authors
- Honggang ZhouCheng YangLei LiuMindie H. NguyenRamsey CheungJie LiBiyao ZouDaniel Q. Huang
- Journals
- International Immunopharmacology (14 papers)Molecules (5 papers)Frontiers in Pharmacology (4 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaohe Li
125 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Infectious Diseases 803
- Hepatology 245
- Neurology 316
- Pulmonary and Respiratory Medicine 588
- Modeling and Simulation 70
Countries citing papers authored by Xiaohe Li
This map shows the geographic impact of Xiaohe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohe Li more than expected).
Fields of papers citing papers by Xiaohe Li
This network shows the impact of papers produced by Xiaohe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohe Li. The network helps show where Xiaohe Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaohe Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 20 | |
| 12 | 2023 | 27 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 7 | |
| 15 | 2023 | 22 | |
| 16 | 2022 | 60 | |
| 17 | 2022 | 15 | |
| 18 | 2021 | 52 | |
| 19 | 2017 | 17 | |
| 20 | 2017 | 17 |
About Xiaohe Li
Xiaohe Li is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 132 papers that have together received 2.9k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers), Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (10 papers), COVID-19 Clinical Research Studies (9 papers), Hepatitis B Virus Studies (9 papers), Spine and Intervertebral Disc Pathology (7 papers), Neonatal Respiratory Health Research (7 papers) and Spinal Fractures and Fixation Techniques (6 papers). The work is most often cited by research in Infectious Diseases (803 citations), Hepatology (245 citations) and Neurology (316 citations). Xiaohe Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Honggang Zhou, Cheng Yang, Lei Liu, Mindie H. Nguyen, Ramsey Cheung, Jie Li, Biyao Zou, Daniel Q. Huang, Zhaofang Jiang and Guobin Zhang. Their work appears in journals such as International Immunopharmacology, Molecules, Frontiers in Pharmacology, Frontiers in Medicine and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.